The 9 analysts offering 12-month price forecasts for Deciphera Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +0.64% increase from the last price of 10.93.
The current consensus among 11 polled investment analysts is to Hold stock in Deciphera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.66
Reporting Date Aug 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.